Qiagen N.V. (QGEN): Dividends Paid

Annual figures by period end, from SEC filings.

$54.24M
Year ended 2025-12-31
2023-12-31: $02024-12-31: $02025-12-31: $54.24M$54.24M
2023-12-31 Dividends Paid (USD) 2025-12-31
Period endedDividends PaidChange YoYSource filing
2025-12-31$54.24Mn/a2026-03-20, From 2025-01-01
2024-12-31$0n/a2026-03-20, From 2024-01-01
2023-12-31$0n/a2026-03-20, From 2023-01-01

Dividends Paid at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDividends PaidChange YoY
Qiagen N.V. (QGEN)2025-12-31$54.24Mn/a
Bio-Techne Corp (TECH)2026-06-30$49.92M-0.9%
Gilead Sciences, Inc. (GILD)2025-12-31$4.00B+2.2%
Monte Rosa Therapeutics, Inc. (GLUE)2025-12-31$0n/a
Amgen Inc (AMGN)2025-12-31$5.12B+6.0%
Scilex Holding Co (SCLX)2024-12-31$8.65M0.0%
Viskase Holdings, Inc. (VISK)2025-12-31$1.27M0.0%
Windtree Therapeutics Inc (WINT)2024-12-31$657.0Kn/a
Vor Biopharma Inc. (VOR)2025-12-31$0n/a

Compare QGEN, TECH, GILD, GLUE side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗